214 Efficacy and safety of switching from adalimumab to sarilumab in an open-label extensionof a phase III monotherapy trial in patients with active rheumatoid arthritis | Zendy

AI Assistant Blog Pricing

214 Efficacy and safety of switching from adalimumab to sarilumab in an open-label extensionof a phase III monotherapy trial in patients with active rheumatoid arthritis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.